Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28486043

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2017 Aug 20
First author
Sekeres MA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Aug 20;35(24):2729-2731. doi: 10.1200/JCO.2017.73.0812.
    note
    Source null
    related pmid
    28548890
    relationship
    Comment in

Authors and identifiers

  1. name
    Sekeres MA
    type
    Author
  2. name
    Othus M
    type
    Author
  3. name
    List AF
    type
    Author
  4. name
    Odenike O
    type
    Author
  5. name
    Stone RM
    type
    Author
  6. name
    Gore SD
    type
    Author
  7. name
    Litzow MR
    type
    Author
  8. name
    Buckstein R
    type
    Author
  9. name
    Fang M
    type
    Author
  10. name
    Roulston D
    type
    Author
  11. name
    Bloomfield CD
    type
    Author
  12. name
    Moseley A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Sekeres MA
    type
    Author
  2. name
    Othus M
    type
    Author
  3. name
    List AF
    type
    Author
  4. name
    Odenike O
    type
    Author
  5. name
    Stone RM
    type
    Author
  6. name
    Gore SD
    type
    Author
  7. name
    Litzow MR
    type
    Author
  8. name
    Buckstein R
    type
    Author
  9. name
    Fang M
    type
    Author
  10. name
    Roulston D
    type
    Author
  11. name
    Bloomfield CD
    type
    Author
  12. name
    Moseley A
    type
    Author
bibliography ids
  1. nci-bib-b93527a8ec22e68f87bfe8ed
book metadata
content sha256
ee230a056cea69338780a3d4f3b467dd02c5bc0c2a9e164c706501f57bf30b70
document type
citation
dois
  1. 10.1200/JCO.2015.66.2510
electronic publication date
display
2017 May 9
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28486043
immutable id
pubmed:28486043@ee230a056cea69338780a3d4f3b467dd02c5bc0c2a9e164c706501f57bf30b70
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
24
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2745-2753
volume
35
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Aug 20;35(24):2729-2731. doi: 10.1200/JCO.2017.73.0812.
    note
    Source null
    related pmid
    28548890
    relationship
    Comment in
outcomes validated
false
pmid
28486043
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
c254abf64e3d3fd97053e3188bd5b03fa2edb8428ce593a997ca8edec1e07878
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 Aug 20
precision
day
year
2017
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28486043/
title
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117.

Preserved source evidence · Not medical advice